Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.
The Indian Pharmaceutical Association (IPA) strongly opposes the ideas which arise through some recent news indicates that there have been discussion regarding enabling the unqualified persons to be "pharmacists" by initiating some training courses. IPA firmly stated that medical stores/pharmacies should be run only in presence and under supervision of qualified, registered pharmacists.



